Sartorius Stedim Biotech S.A. (EPA:DIM)
France · Delayed Price · Currency is EUR 211.80
-3.20 (-1.49%)
Oct 19, 2026, 5:35 PM CET
Sartorius Stedim Biotech Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 20,607 | 20,433 | 18,363 | 22,073 | 27,883 | 44,467 | |
Market Cap Growth | 4.54% | 11.28% | -16.81% | -20.84% | -37.29% | 65.66% |
Enterprise Value | 22,816 | 22,733 | 20,749 | 25,782 | 28,964 | 44,979 |
Last Close Price | 211.80 | 209.15 | 187.23 | 237.01 | 297.92 | 473.53 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 70.37 | 76.93 | 104.87 | 71.14 | 31.83 | 107.31 |
Forward PE | 38.48 | 40.98 | 46.49 | 49.64 | 31.48 | 60.28 |
PS Ratio | 6.86 | 6.89 | 6.61 | 7.95 | 7.98 | 15.40 |
PB Ratio | 4.85 | 4.95 | 4.56 | 8.26 | 11.09 | 25.66 |
P/TBV Ratio | - | - | - | - | 46.41 | 163.54 |
P/FCF Ratio | 52.26 | 68.34 | 38.63 | 80.91 | 153.46 | 117.67 |
P/OCF Ratio | 26.13 | 29.52 | 22.53 | 29.57 | 45.54 | 63.35 |
PEG Ratio | 2.38 | 1.86 | 2.29 | 6.24 | 1.67 | 6.53 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 7.59 | 7.66 | 7.46 | 9.29 | 8.29 | 15.58 |
EV/EBITDA Ratio | 27.16 | 29.22 | 32.97 | 39.20 | 24.20 | 43.61 |
EV/EBIT Ratio | 40.10 | 42.25 | 52.40 | 54.93 | 27.47 | 48.88 |
EV/FCF Ratio | 57.86 | 76.03 | 43.65 | 94.51 | 159.41 | 119.02 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.57 | 0.63 | 0.71 | 1.38 | 0.45 | 0.36 |
Debt / EBITDA Ratio | 2.85 | 3.23 | 4.38 | 5.39 | 0.93 | 0.60 |
Debt / FCF Ratio | 6.09 | 8.69 | 6.04 | 13.50 | 6.25 | 1.66 |
Net Debt / Equity Ratio | 0.52 | 0.53 | 0.54 | 1.33 | 0.40 | 0.23 |
Net Debt / EBITDA Ratio | 2.69 | 2.78 | 3.47 | 5.41 | 0.84 | 0.38 |
Net Debt / FCF Ratio | 5.58 | 7.24 | 4.59 | 13.03 | 5.52 | 1.03 |
Asset Turnover | 0.37 | 0.37 | 0.35 | 0.43 | 0.78 | 0.85 |
Inventory Turnover | 2.35 | 2.36 | 2.01 | 1.62 | 1.85 | 2.13 |
Quick Ratio | 0.48 | 0.47 | 1.05 | 0.49 | 0.53 | 0.59 |
Current Ratio | 1.16 | 1.02 | 1.85 | 1.51 | 1.61 | 1.40 |
Return on Equity (ROE) | 7.09% | 6.53% | 5.33% | 12.05% | 41.43% | 25.94% |
Return on Assets (ROA) | 4.40% | 4.14% | 3.10% | 4.59% | 14.62% | 16.90% |
Return on Invested Capital (ROIC) | 6.44% | 6.14% | 5.19% | 7.49% | 29.10% | 28.75% |
Return on Capital Employed (ROCE) | 8.50% | 8.20% | 5.40% | 6.90% | 26.20% | 31.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.42% | 1.30% | 0.95% | 1.41% | 3.14% | 0.93% |
FCF Yield | 1.91% | 1.46% | 2.59% | 1.24% | 0.65% | 0.85% |
Dividend Yield | 0.33% | 0.33% | 0.37% | 0.29% | 0.48% | 0.26% |
Payout Ratio | 22.93% | 25.26% | 38.32% | 42.77% | 13.25% | 15.13% |
Buyback Yield / Dilution | 0.19% | -0.54% | -5.01% | 0.00% | 0.01% | 0.00% |
Total Shareholder Return | 0.51% | -0.21% | -4.64% | 0.29% | 0.49% | 0.26% |